SalioGen is a Massachusetts-based biotechnology company that develops and commercializes genetic therapies for the treatment of inherited disorders.
Business Model:
Revenue: $5M
Employees: 11-50
Address: 245 First Street
City: Cambridge
State: MA
Zip: 02142
Country: US
SalioGen is a Massachusetts-based biotechnology company that develops and commercializes genetic therapies for the treatment of inherited disorders.
Contact Phone:
+18579902200
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | Series B | $0 |
Cystic Fibrosis Foundation D1 Capital Partners EPIQ Capital Group Fidelity Management and Research Company GordonMD Global Investments Retinal Degeneration Fund SymBiosis LLC T. Rowe Price Cystic Fibrosis Foundation D1 Capital Partners EPIQ Capital Group Fidelity Management and Research Company GordonMD Global Investments Retinal Degeneration Fund SymBiosis LLC T. Rowe Price |
2/2021 | Series A | $0 |
PBM Capital Group PBM Capital Group |
1/2022 | Series B | 8 | $115M |
Cystic Fibrosis Foundation GordonMD Global Investments EPIQ Capital Group Fidelity Management & Research Company LLC PBM Capital Cystic Fibrosis Foundation D1 Capital Partners EPIQ Capital Group Fidelity Management and Research Company GordonMD Global Investments Retinal Degeneration Fund SymBiosis LLC T. Rowe Price |
2/2021 | Series A | 1 | $20M |
PBM Capital PBM Capital Group |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|